Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure
Robel K Gebre(Mayo Clinic), Clifford R. Jack(Mayo Clinic), Alejandro Costoya‐Sánchez(Universidade de Santiago de Compostela), Anthony J. Spychalla(Mayo Clinic), Prashanthi Vemuri(Mayo Clinic in Arizona), Melissa E. Murray(Jacksonville College), David S. Knopman(Mayo Clinic), Fiona Heeman(Amsterdam University Medical Centers), Michael Schöll(National Hospital for Neurology and Neurosurgery), Jonathan Graff-Radford(Mayo Clinic), Christopher G. Schwarz(Mayo Clinic), Sheelakumari Raghavan(Mayo Clinic), Ronald Petersen(Mayo Clinic), Val J. Lowe(Mayo Clinic in Arizona), Heather J. Wiste(Mayo Clinic in Florida)
Cited by 11
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.1k
Primary age-related tauopathy (PART): a common pathology associated with human aging
|Acta Neuropathologica|2014|1.5k